Akers Biosciences names new CEO

Thorofare-based Akers Biosciences Inc. announced it has a new CEO.

Howard R. Yeaton has been appointed to CEO, effective immediately. He is replacing John J. Gormally, who resigned both as CEO and member of the board of directors.

Yeaton will not be a member of the company’s board of directors, but will work closely with it and report to them.

Yeaton, who has more than 30 years of senior financial and strategic business experience, was serving as a consultant to Akers since April. Before that, he was managing principal of Financial Consulting Strategies LLC. He was also interim chief financial officer of Propel Media Inc. and interim CFO for Energeous Corp. In addition, he also served in financial leadership roles for Konica and Teco Energy. He began his career at Deloitte.

He current serves as director, vice chairman and chairman of the audit committee for Stewardship Financial Corp.